Cargando…

Effect of Vitamin D supplementation on reduction in levels of HbA1 in patients recently diagnosed with type 2 Diabetes Mellitus having asymptomatic Vitamin D deficiency

OBJECTIVE: To study the effect of Vitamin D supplementation on reduction in level of HbA1 in patients recently diagnosed with diabetes mellitus Type II having asymptomatic Vitamin D deficiency. METHODS: This randomized control trial was conducted at East Medical Ward Mayo Hospital Lahore for 6 month...

Descripción completa

Detalles Bibliográficos
Autores principales: Randhawa, Fawad Ahmad, Mustafa, Saqib, Khan, Dur Muhammad, Hamid, Shahid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Professional Medical Publications 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5648957/
https://www.ncbi.nlm.nih.gov/pubmed/29067058
http://dx.doi.org/10.12669/pjms.334.12288
_version_ 1783272475850702848
author Randhawa, Fawad Ahmad
Mustafa, Saqib
Khan, Dur Muhammad
Hamid, Shahid
author_facet Randhawa, Fawad Ahmad
Mustafa, Saqib
Khan, Dur Muhammad
Hamid, Shahid
author_sort Randhawa, Fawad Ahmad
collection PubMed
description OBJECTIVE: To study the effect of Vitamin D supplementation on reduction in level of HbA1 in patients recently diagnosed with diabetes mellitus Type II having asymptomatic Vitamin D deficiency. METHODS: This randomized control trial was conducted at East Medical Ward Mayo Hospital Lahore for 6 months from January 01 2016 to June 30, 2016. 114 Patients were included through non probability purposive sampling technique. Informed consent and demographic information was collected. Patients were divided in two groups by randomization through tossing a coin. Group-A patients received Metformin tablet alone at 500 mg after dinner and Group-B patients were treated with same dosage of Metformin along with oral vitamin D at 200,000 IU monthly for three months. Blood sample was obtained at baseline, 3 months and 6 months of initiation of therapy. All samples were sent to the laboratory for complete blood count, blood sugar fasting, serum calcium, serum phosphorous, serum alkaline phosphatase, HbA1c and serum 25 Hyroxy Vitamin D (S-25(OH) D) levels and iPTH. Data entry and analysis was done by using SPSS 20. RESULTS: The mean age of patients in metformin group was 42.37±4.59 years while mean age of patients in combination group was 43.33±4.86years. Males were 45.6% and females were 54.4% in metformin group while in combination group, 36.8% were males’ and 63.2% were females’. At baseline, in metformin group, mean Vitamin D level was 17.09±1.73mg/dl and in combination group, mean Vitamin D level was 16.49±1.56mg/dl. The difference was insignificant (p>0.05). On 2nd visit, combination group mean Vitamin D was 29.04±3.96mg/dl. At baseline, 1(st) and 2(nd) visit, in metformin group, mean HbA1c was 7.59±0.47%, 7.46±0.25% and 7.30±0.29%. At baseline, 1(st) and 2(nd) visit, in combination group, mean HbA1c was 7.71±0.19%, 7.57±0.21% and 7.43±0.26%. The difference was insignificant (p>0.05) at baseline while significant on later follow-ups (P<0.05). CONCLUSION: Vitamin D supplementation improved the glycemic control but substantial reduction in HbA1c was statistically insignificant in both groups.
format Online
Article
Text
id pubmed-5648957
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Professional Medical Publications
record_format MEDLINE/PubMed
spelling pubmed-56489572017-10-24 Effect of Vitamin D supplementation on reduction in levels of HbA1 in patients recently diagnosed with type 2 Diabetes Mellitus having asymptomatic Vitamin D deficiency Randhawa, Fawad Ahmad Mustafa, Saqib Khan, Dur Muhammad Hamid, Shahid Pak J Med Sci Original Article OBJECTIVE: To study the effect of Vitamin D supplementation on reduction in level of HbA1 in patients recently diagnosed with diabetes mellitus Type II having asymptomatic Vitamin D deficiency. METHODS: This randomized control trial was conducted at East Medical Ward Mayo Hospital Lahore for 6 months from January 01 2016 to June 30, 2016. 114 Patients were included through non probability purposive sampling technique. Informed consent and demographic information was collected. Patients were divided in two groups by randomization through tossing a coin. Group-A patients received Metformin tablet alone at 500 mg after dinner and Group-B patients were treated with same dosage of Metformin along with oral vitamin D at 200,000 IU monthly for three months. Blood sample was obtained at baseline, 3 months and 6 months of initiation of therapy. All samples were sent to the laboratory for complete blood count, blood sugar fasting, serum calcium, serum phosphorous, serum alkaline phosphatase, HbA1c and serum 25 Hyroxy Vitamin D (S-25(OH) D) levels and iPTH. Data entry and analysis was done by using SPSS 20. RESULTS: The mean age of patients in metformin group was 42.37±4.59 years while mean age of patients in combination group was 43.33±4.86years. Males were 45.6% and females were 54.4% in metformin group while in combination group, 36.8% were males’ and 63.2% were females’. At baseline, in metformin group, mean Vitamin D level was 17.09±1.73mg/dl and in combination group, mean Vitamin D level was 16.49±1.56mg/dl. The difference was insignificant (p>0.05). On 2nd visit, combination group mean Vitamin D was 29.04±3.96mg/dl. At baseline, 1(st) and 2(nd) visit, in metformin group, mean HbA1c was 7.59±0.47%, 7.46±0.25% and 7.30±0.29%. At baseline, 1(st) and 2(nd) visit, in combination group, mean HbA1c was 7.71±0.19%, 7.57±0.21% and 7.43±0.26%. The difference was insignificant (p>0.05) at baseline while significant on later follow-ups (P<0.05). CONCLUSION: Vitamin D supplementation improved the glycemic control but substantial reduction in HbA1c was statistically insignificant in both groups. Professional Medical Publications 2017 /pmc/articles/PMC5648957/ /pubmed/29067058 http://dx.doi.org/10.12669/pjms.334.12288 Text en Copyright: © Pakistan Journal of Medical Sciences http://creativecommons.org/licenses/by/3.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Randhawa, Fawad Ahmad
Mustafa, Saqib
Khan, Dur Muhammad
Hamid, Shahid
Effect of Vitamin D supplementation on reduction in levels of HbA1 in patients recently diagnosed with type 2 Diabetes Mellitus having asymptomatic Vitamin D deficiency
title Effect of Vitamin D supplementation on reduction in levels of HbA1 in patients recently diagnosed with type 2 Diabetes Mellitus having asymptomatic Vitamin D deficiency
title_full Effect of Vitamin D supplementation on reduction in levels of HbA1 in patients recently diagnosed with type 2 Diabetes Mellitus having asymptomatic Vitamin D deficiency
title_fullStr Effect of Vitamin D supplementation on reduction in levels of HbA1 in patients recently diagnosed with type 2 Diabetes Mellitus having asymptomatic Vitamin D deficiency
title_full_unstemmed Effect of Vitamin D supplementation on reduction in levels of HbA1 in patients recently diagnosed with type 2 Diabetes Mellitus having asymptomatic Vitamin D deficiency
title_short Effect of Vitamin D supplementation on reduction in levels of HbA1 in patients recently diagnosed with type 2 Diabetes Mellitus having asymptomatic Vitamin D deficiency
title_sort effect of vitamin d supplementation on reduction in levels of hba1 in patients recently diagnosed with type 2 diabetes mellitus having asymptomatic vitamin d deficiency
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5648957/
https://www.ncbi.nlm.nih.gov/pubmed/29067058
http://dx.doi.org/10.12669/pjms.334.12288
work_keys_str_mv AT randhawafawadahmad effectofvitamindsupplementationonreductioninlevelsofhba1inpatientsrecentlydiagnosedwithtype2diabetesmellitushavingasymptomaticvitaminddeficiency
AT mustafasaqib effectofvitamindsupplementationonreductioninlevelsofhba1inpatientsrecentlydiagnosedwithtype2diabetesmellitushavingasymptomaticvitaminddeficiency
AT khandurmuhammad effectofvitamindsupplementationonreductioninlevelsofhba1inpatientsrecentlydiagnosedwithtype2diabetesmellitushavingasymptomaticvitaminddeficiency
AT hamidshahid effectofvitamindsupplementationonreductioninlevelsofhba1inpatientsrecentlydiagnosedwithtype2diabetesmellitushavingasymptomaticvitaminddeficiency